Kalehua Capital Management »

Compass Pathways shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.5M 820k 5.53

More positions owned by Kalehua Capital Management

Alpha Architect 1-3 Month Box ETF Alpha Arch 1-3 (BOXX)
X4 Pharmaceuticals Com New (XFOR)
Surrozen Com New (SRZN)
Veradermics Common Stock
Relay Therapeutics (RLAY)
Sionna Therapeutics (SION)
Aclaris Therapeutics (ACRS)
Inhibikase Therapeutics Com New (IKT)
Oruka Therapeutics (ORKA)
Pharvaris N V (PHVS)
Uniqure NV SHS (QURE)
Septerna (SEPN)
Compass Pathways Sponsored Ads (CMPS)
Athira Pharma (LONA)
Damora Therapeutics Com New (DMRA)

View all positions for Kalehua Capital Management

Top funds holding Compass Pathways

Deep Track Capital
Rtw Investments
Tang Capital Management
BIT Capital GmbH
ARK Investment Management
Millennium Management
GMT Capital Corp
Two Sigma Investments
DAFNA Capital Management
Baker Bros. Advisors
Eagle Health Investments
UBS Group
Susquehanna International
Leucadia National Corporation
Aisling Capital Management

View all funds holding Compass Pathways